WallStreetZenWallStreetZen

NASDAQ: LPTX
Leap Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for LPTX

Based on 4 analysts offering 12 month price targets for Leap Therapeutics Inc.
Min Forecast
$7.00+133.33%
Avg Forecast
$11.38+279.17%
Max Forecast
$17.50+483.33%

Should I buy or sell LPTX stock?

Based on 4 analysts offering ratings for Leap Therapeutics Inc.
Strong Buy
Strong Buy
1 analysts 25%
Buy
3 analysts 75%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their LPTX stock forecasts and price targets.

LPTX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-19
lockedlocked$00.00+00.00%2024-03-19
lockedlocked$00.00+00.00%2023-11-20
lockedlocked$00.00+00.00%2023-11-14

1 of 1

Forecast return on equity

Is LPTX forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.72%

Forecast return on assets

Is LPTX forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

LPTX revenue forecast

What is LPTX's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$103.5M
Avg 2 year Forecast
$105.0M
Avg 3 year Forecast
$162.4M

LPTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
LPTX$3.00$11.38+279.17%Strong Buy
LVTX$2.94$6.00+104.08%Buy
ONCY$1.04$4.00+284.62%Buy
ANEB$3.00N/AN/A
QTTB$24.12$47.50+96.93%Strong Buy
View Top Biotech Stocks

Leap Therapeutics Stock Forecast FAQ

Is Leap Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: LPTX) stock is to Strong Buy LPTX stock.

Out of 4 analysts, 1 (25%) are recommending LPTX as a Strong Buy, 3 (75%) are recommending LPTX as a Buy, 0 (0%) are recommending LPTX as a Hold, 0 (0%) are recommending LPTX as a Sell, and 0 (0%) are recommending LPTX as a Strong Sell.

If you're new to stock investing, here's how to buy Leap Therapeutics stock.

What is LPTX's revenue growth forecast for 2025-2027?

(NASDAQ: LPTX) Leap Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.32%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.27%.

Leap Therapeutics's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast LPTX's revenue for 2025 to be $2,649,614,180, with the lowest LPTX revenue forecast at $2,649,614,180, and the highest LPTX revenue forecast at $2,649,614,180. On average, 2 Wall Street analysts forecast LPTX's revenue for 2026 to be $2,686,862,379, with the lowest LPTX revenue forecast at $153,600,822, and the highest LPTX revenue forecast at $5,220,123,936.

In 2027, LPTX is forecast to generate $4,157,462,249 in revenue, with the lowest revenue forecast at $739,075,955 and the highest revenue forecast at $7,575,848,542.

What is LPTX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: LPTX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is LPTX's Price Target?

According to 4 Wall Street analysts that have issued a 1 year LPTX price target, the average LPTX price target is $11.38, with the highest LPTX stock price forecast at $17.50 and the lowest LPTX stock price forecast at $7.00.

On average, Wall Street analysts predict that Leap Therapeutics's share price could reach $11.38 by Mar 19, 2025. The average Leap Therapeutics stock price prediction forecasts a potential upside of 279.17% from the current LPTX share price of $3.00.

What is LPTX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: LPTX) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.